Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Ross

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Small Methods|June 15, 2023
Understanding Intracellular Biology to Improve mRNA Delivery by Lipid NanoparticlesMorag Rose Hunter, Lili Cui, Benjamin Thomas Porebski, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 19, 2014
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in ItalyDomenico Italiano, Elisa Bianchini, Maura Ilardi, et al.
Drug Safety|December 30, 2011
Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control studyGianluca Trifirò, M Mostafa Mokhles, Jeanne P Dieleman, et al.
International Journal of Molecular Sciences|December 6, 2019
Phenotypic Screen with the Human Secretome Identifies FGF16 as Inducing Proliferation of iPSC-Derived Cardiac Progenitor CellsKarin Jennbacken, Fredrik Wågberg, Ulla Karlsson, et al.
Scientific Reports|August 19, 2021
Secretome screening reveals immunomodulating functions of IFNα-7, PAP and GDF-7 on regulatory T-cellsMei Ding, Rajneesh Malhotra, Tomas Ottosson, et al.
Pharmacological Research|November 30, 2011
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's diseaseM Mostafa Mokhles, Gianluca Trifirò, Jeanne P Dieleman, et al.
Head & Neck|January 18, 2014
Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care CollaborativeMark L Urken, Mira Milas, Gregory W Randolph, et al.
Plastic and Reconstructive Surgery. Global Open|March 3, 2022
Canadian Expert Opinion on Breast Reconstruction Access: Strategies to Optimize Care during COVID-19Kathryn V Isaac, Edward W Buchel, Muriel M Brackstone, et al.
Scientific Reports|February 22, 2022
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testingOona Delpuech, Julie A Douthwaite, Thomas Hill, et al.
Molecular Cancer Therapeutics|July 19, 2011
Potent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer modelsMatthew Squires, George Ward, Gordan Saxty, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Small Methods|June 15, 2023
Understanding Intracellular Biology to Improve mRNA Delivery by Lipid NanoparticlesMorag Rose Hunter, Lili Cui, Benjamin Thomas Porebski, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 19, 2014
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in ItalyDomenico Italiano, Elisa Bianchini, Maura Ilardi, et al.
Drug Safety|December 30, 2011
Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control studyGianluca Trifirò, M Mostafa Mokhles, Jeanne P Dieleman, et al.
International Journal of Molecular Sciences|December 6, 2019
Phenotypic Screen with the Human Secretome Identifies FGF16 as Inducing Proliferation of iPSC-Derived Cardiac Progenitor CellsKarin Jennbacken, Fredrik Wågberg, Ulla Karlsson, et al.
Scientific Reports|August 19, 2021
Secretome screening reveals immunomodulating functions of IFNα-7, PAP and GDF-7 on regulatory T-cellsMei Ding, Rajneesh Malhotra, Tomas Ottosson, et al.
Pharmacological Research|November 30, 2011
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's diseaseM Mostafa Mokhles, Gianluca Trifirò, Jeanne P Dieleman, et al.
Head & Neck|January 18, 2014
Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care CollaborativeMark L Urken, Mira Milas, Gregory W Randolph, et al.
Plastic and Reconstructive Surgery. Global Open|March 3, 2022
Canadian Expert Opinion on Breast Reconstruction Access: Strategies to Optimize Care during COVID-19Kathryn V Isaac, Edward W Buchel, Muriel M Brackstone, et al.
Scientific Reports|February 22, 2022
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testingOona Delpuech, Julie A Douthwaite, Thomas Hill, et al.
Molecular Cancer Therapeutics|July 19, 2011
Potent, selective inhibitors of fibroblast growth factor receptor define fibroblast growth factor dependence in preclinical cancer modelsMatthew Squires, George Ward, Gordan Saxty, et al.
Pageof 9